Evidence map›Paper›PMID 24586795›Full record

ArticlePloS one2014

Evidence that HIV-1 CRF01_AE is associated with low CD4+T cell count and CXCR4 co-receptor usage in recently infected young men who have sex with men (MSM) in Shanghai, China.

Xiaoshan Li, Yile Xue, Leiming Zhou, Yi Lin, Xiaolei Yu, Xuqin Wang, Xiaohong Zhen, Wei Zhang, Zhen Ning, Qing Yue and 15 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 43 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 4 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 4 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. A New HIV-1 KMicrobiology spectrum · 2022
    Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

25 authors at 3 institutions in 2 countries.

Xiaoshan LiDepartment of AIDS and STD, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China; Shanghai Municipal Institutes for Preventive Medicine, Shanghai, China ; Public Health College, Nantong University, Nantong, China.
Yile XueDepartment of AIDS and STD, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China; Shanghai Municipal Institutes for Preventive Medicine, Shanghai, China.
Leiming ZhouDepartment of AIDS and STD, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China; Shanghai Municipal Institutes for Preventive Medicine, Shanghai, China.
Yi LinDepartment of AIDS and STD, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China; Shanghai Municipal Institutes for Preventive Medicine, Shanghai, China.
Xiaolei YuDepartment of AIDS and STD, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China; Shanghai Municipal Institutes for Preventive Medicine, Shanghai, China.
Xuqin WangDepartment of AIDS and STD, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China; Shanghai Municipal Institutes for Preventive Medicine, Shanghai, China.
Xiaohong ZhenDepartment of AIDS and STD, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China; Shanghai Municipal Institutes for Preventive Medicine, Shanghai, China.
Wei ZhangDepartment of AIDS and STD, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China; Shanghai Municipal Institutes for Preventive Medicine, Shanghai, China.
Zhen NingDepartment of AIDS and STD, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China; Shanghai Municipal Institutes for Preventive Medicine, Shanghai, China.
Qing YueDepartment of AIDS and STD, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China; Shanghai Municipal Institutes for Preventive Medicine, Shanghai, China.
Jie FuDepartment of AIDS and STD, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China; Shanghai Municipal Institutes for Preventive Medicine, Shanghai, China.
Fangwei ShenDepartment of AIDS and STD, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China; Shanghai Municipal Institutes for Preventive Medicine, Shanghai, China.
Jing GaiDepartment of AIDS and STD, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China; Shanghai Municipal Institutes for Preventive Medicine, Shanghai, China.
Yuqing XuDepartment of AIDS and STD, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China; Shanghai Municipal Institutes for Preventive Medicine, Shanghai, China.
Jiawen MaoDepartment of AIDS and STD, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China; Shanghai Municipal Institutes for Preventive Medicine, Shanghai, China.
Xianming GaoDepartment of AIDS and STD, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China; Shanghai Municipal Institutes for Preventive Medicine, Shanghai, China.
Xiaopei ShenDepartment of AIDS and STD, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China; Shanghai Municipal Institutes for Preventive Medicine, Shanghai, China.
Laiyi KangDepartment of AIDS and STD, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China; Shanghai Municipal Institutes for Preventive Medicine, Shanghai, China.
Guido VanhamImmunovirology Group, Biomedical Science Department, Institute of Tropical Medicine, Antwerp, Belgium.
Hua ChengDepartment of AIDS and STD, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China; Shanghai Municipal Institutes for Preventive Medicine, Shanghai, China.
Ying WangDepartment of AIDS and STD, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China; Shanghai Municipal Institutes for Preventive Medicine, Shanghai, China.
Minghua ZhuangDepartment of AIDS and STD, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China; Shanghai Municipal Institutes for Preventive Medicine, Shanghai, China.
Xun ZhuangPublic Health College, Nantong University, Nantong, China.
Qichao PanDepartment of AIDS and STD, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China; Shanghai Municipal Institutes for Preventive Medicine, Shanghai, China.
Ping ZhongDepartment of AIDS and STD, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China; Shanghai Municipal Institutes for Preventive Medicine, Shanghai, China.
Shanghai Municipal Center For Disease Control Prevention · CNNantong University · CNInstituut voor Tropische Geneeskunde · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Men who have sex with men (MSM) have recently accounted for an alarmingly increasing proportion of HIV-1 transmission in China. In order to investigate the immune status as a result of CRF01_AE infection and CXCR4 co-receptor usage in a young Shanghai-based HIV-1-infected MSM population in Shanghai, 364 HIV-1-infected MSM with average age of 22.7 years old, newly diagnosed between Jan 2009 and Jul 2013 were analyzed for CD4+T cell count, subtyping using phylogenetic analysis, and viral co-receptor tropism using Geno2pheno and webPSSM in combination. A total of 276 individuals were identified as recently infected. Subtype assignment were as follows: 176 (63.8%) CRF01_AE, 77 (27.9%) CRF07_BC, and 23 (8.3%) subtype B. Besides, 24 second-generation recombinant strains were identified. A lower CD4+T cell count at baseline survey was observed among CRF01_AE strain-infected individuals, compared to those who were infected with CRF07_BC (P<0.01). The frequency of baseline CD4+T cell count <200 was higher and the frequency of CD4 T counts >500 lower in CRF01_AE infection than CRF07_BC infection. It is worth noting that 32.4%-40.9% of CRF01_AE strain-infected individuals were predicted to carry CXCR4-tropic viruses whereas none of CRF07_BC and subtype B were found to be as CXCR4-tropic viruses (P<0.001). As could be expected CXCR4 tropism was associated with lower CD4 T counts. This study revealed that CRF01_AE strains with high frequency of CXCR4 tropism are prevailing in the young MSM population in China and could potentially cause a severe loss of CD4+T cell count and rapid disease progression. A regular surveillance of HIV-1 subtypes, CD4+T cell count and viral co-receptor usage would be greatly beneficial for effectively monitoring disease progression, improvement of antiretroviral therapy strategy and prompt intervention of transmission.

Indexed as

Homosexuality, MaleAdolescentAdultCD4-Positive T-LymphocytesChinaHIV InfectionsHIV SeropositivityHumansLymphocyte CountMaleReceptors, CXCR4Young AdultCXCR4 protein, humanReceptors, CXCR4

Identifiers

PMID24586795
PMCPMC3931781
OpenAlexW2051499965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.